Laddar…
Academic Journal
Prospects of laboratory risk evaluation of multiple sclerosis relapse and progressing
I. V. Smagina, S. A. Yelchaninova, A. V. Popovtseva, Yu. N. Ignatova, A. O. Gridina, A. S. Fedyanin
Бюллетень сибирской медицины, Vol 9, Iss 4, Pp 152-155 (2010)
Sparad:
| Titel | Prospects of laboratory risk evaluation of multiple sclerosis relapse and progressing |
|---|---|
| Författarna | I. V. Smagina, S. A. Yelchaninova, A. V. Popovtseva, Yu. N. Ignatova, A. O. Gridina, A. S. Fedyanin |
| Utgivningsår |
2010
|
| Källa |
Бюллетень сибирской медицины, Vol 9, Iss 4, Pp 152-155 (2010)
|
| Beskrivning |
The Relapsing-Remitting Multiple Sclerosis (MS) patients research has revealed that the matrix metalloproteinase-2 level in cerebrospinal fluid which is higher then 30 ng/ml during the relapse and/or remission period increases repeated relapse risk during 2 years term by 2.8 times. The rapid MS progressing is associated with the high level of adhesion molecule (sPECAM) in cerebrospinal fluid.
|
| Dokumenttyp |
article
|
| Språk |
English
Russian |
| Information om utgivare |
Siberian State Medical University (Tomsk), 2010.
|
| Ämnestermer | |
